Current drug treatment of epilepsy in adults (Q35958968)

11 August 2017

1 reference

title

Current drug treatment of epilepsy in adults (English)

1 reference

11 August 2017

Dougall McCorry

1

1 reference

11 August 2017

David Chadwick

series ordinal

2

1 reference

11 August 2017

Anthony Marson

series ordinal

3

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

3

1 reference

11 August 2017

12

1 reference

11 August 2017

729-735

1 reference

Remission of Seizures and Relapse in Patients with Epilepsy

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Disease modification in partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Do seizures beget seizures? An assessment of the clinical evidence in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Antiepileptic drugs as a cause of worsening seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Exacerbation of seizures in children by carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Absence seizures and carbamazepine in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

New antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Comparison of oxcarbazepine and carbamazepine: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Juvenile myoclonic epilepsy of Janz.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Visual field constriction in children with epilepsy on vigabatrin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Visual field defects associated with vigabratin monotherapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Randomized trial of vigabatrin in patients with infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Fracture risk is increased in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Effect of antiepileptic drugs on bone density in ambulatory patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Evaluation of bone mineral density in children receiving antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Management issues for women with epilepsy: neural tube defects and folic acid supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Additional educational needs in children born to mothers with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Epilepsy after the first drug fails: substitution or add-on?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900935-4

7 January 2021

10.1016/S1474-4422(04)00935-4

Identifiers

DOI

1 reference

release_lwoltdwk2bfpvlxj7ettegs6je

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lwoltdwk2bfpvlxj7ettegs6je

24 November 2022

mapped directly with Wikidata item

1 reference